HEALTH CARE M&A ACTIVITY FOR THE THIRD QUARTER
| FOR IMMEDIATE RELEASE | Stephen M. Monroe, Partner Sanford B. Steever, Editor 800-248-1668 203-846-6800 Fax: 203-846-8300 pressreleases@levinassociates.com |
NORWALK, CT – October 8, 2008 – According to a new Report from Irving Levin Associates, a total of 251 mergers and acquisitions were announced in the health care industry during the third quarter of 2008, an 8% decrease from the 274 deals announced in the prior quarter. However, based on preliminary figures, a total of $88.9 billion was committed to fund the third quarter’s M&A activity, a 3% increase over the prior quarter’s $86.2 billion. It also represents a 20% increase over the $74.2 billion spent in Q3:06 and a 78% increase over the $49.9 billion spent in Q3:07. Despite the credit crunch, M&A activity in the health care industry remains robust.
|
The Health Care M&A Market Third Quarter 2008
Dollar Amounts By Sector*
|
||
|
Sector
|
Dollar Amount
Third Quarter 2008
|
Percent of Quarter
|
|
Long-Term Care
|
$ 1,208,120,000
|
1%
|
|
Hospitals
|
623,900,000
|
<1%
|
|
Managed Care
|
372,000,000
|
<1%
|
|
Physician Medical Groups
|
112,300,000
|
<1%
|
|
Labs, MRI, Dialysis
|
46,000,000
|
<1%
|
|
Behavioral Health Care
|
13,420,000
|
<1%
|
|
Home Health Care
|
11,900,000
|
<1%
|
|
Rehabilitation
|
2,425,000
|
<1%
|
|
Other Services
|
3,817,250,000
|
4%
|
|
Services subtotal
|
$ 6,207,297,000
|
7%
|
|
|
|
|
|
Biotechnology
|
$ 56,435,828,047
|
63%
|
|
Pharmaceuticals
|
22,377,914,600
|
25%
|
|
Medical Devices
|
3,569,445,200
|
4%
|
|
e-Health
|
378,200,000
|
<1%
|
|
Technology subtotal
|
$ 82,761,387,847
|
93%
|
|
Total health care
|
$ 88,968,684,847
|
100%
|
The number of deals announced in each sector of the health care industry appears in the chart below, along with comparisons to the prior quarter (Q2:08) and the year-ago quarter (Q3:07).
|
The Health Care M&A Market Q3:08 – Deal Volume By SectoR
*Preliminary Figures
|
The technology sectors of the health care industry are providing strategic buyers and investors with many acquisition opportunities. “Big pharma has been pouring billions into acquiring biotech companies because their drugs will replace blockbusters going off patent and they are technically difficult for generic companies to copy,” commented Stephen M. Monroe, managing editor at Irving Levin Associates. “The Medical Device and e-Health sectors also continue to attract M&A dollars because the products and solutions they offer can make health care treatment, its coordination and its delivery more efficient and cost-effective.”
“While companies need to get more creative in financing deals in the current credit turmoil, the underlying reasons to pursue health care mergers and acquisitions remain firmly in place: to consolidate fragmented providers, to achieve economies of scale, to meet increasing demand for services and new technologies, to name just a few,” summarized Mr. Steever. “Although the health care M&A market isn’t a perpetual motion machine, it is doing a pretty good imitation of one.”
For more information on The Health Care M&A Information Service, The Health Care Acquisition Report or for a subscription to any Irving Levin publication, call 800-248-1668. Irving Levin Associates, Inc., established in 1948, has headquarters in Norwalk, CT. This privately held corporation publishes research reports and newsletters, and maintains merger and acquisition and venture capital databases, on the health care and senior housing markets.
- Press Releases:





